# A Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma.

Source: https://onco.cc/trials/nct07826949/  
OnCo record `nct07826949` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1 trial of SRN-101 run by Nicholas Butowski, not yet recruiting.

## Summary

A Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma. is a phase 1 interventional study registered as NCT07826949 by Nicholas Butowski, with 6 participants planned, started 2026-11-15. Conditions recorded: Recurrent High-Grade Gliomas, Brain Neoplasm and Glioma. Interventions recorded: SRN-101, Blood Specimen Collection, Surgical Resection and Magnetic Resonance Imaging (MRI).

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07826949
- Phase: 1
- Setting: A Phase 1 Window-of-Opportunity Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma.
- Sponsor: Nicholas Butowski
- Enrolled: 6

## Sources

- ClinicalTrials.gov NCT07826949: https://clinicaltrials.gov/study/NCT07826949

## Connected records

- cancers: [Brain and spinal cord tumours (all types)](https://onco.cc/cancers/brain-tumours/)
- drugs: [SRN-101](https://onco.cc/drugs/srn-101/)
- companies: [Siren Biotechnology](https://onco.cc/companies/siren-biotechnology/)

---
JSON: https://onco.cc/api/v1/entities/nct07826949.json